RIC: Research Interest Comparator

Chang, Alice, M.D.
Affiliation: UTSW
Email: not provided
Home Page: not provided
New This Month | New This Year | Abstract | Selected Publications | RIC Statistics Results - FULL MEDLINE:

Personality disorders come of age.
Glen O Gabbard
Am J Psychiatry 2005 May; 162(5)833-5.

Score: 0.811
Failed to fetch article title! Article may not be available.
Score: 0.790
Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
Judith M Adams ... Janet E Hall
J Clin Endocrinol Metab 2004 Sep; 89(9)4343-50.

Score: 0.729
Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
Richard S Legro ... Andrea Dunaif
J Clin Endocrinol Metab 2005 May; 90(5)2571-9.

Score: 0.634
Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors.
Uberto Pagotto ... Renato Pasquali
Lancet 2005 Apr 16-22; 365(9468)1363-4.

Score: 0.632
Diabetes in the elderly and in women: cardiovascular risks.
James R Sowers
Cardiol Clin 2004 Nov; 22(4)541-51, vi.

Score: 0.630
Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk.
Rod Jackson ... Anthony Rodgers
Lancet 2005 Jan 29-Feb 4; 365(9457)434-41.

Score: 0.628
Cardiovascular health in women with polycystic ovary syndrome.
Sara Sukalich ... David Guzick
Semin Reprod Med 2003 Aug; 21(3)309-15.

Score: 0.616
The importance of diagnosing the polycystic ovary syndrome.
R A Lobo ... E Carmina
Ann Intern Med 2000 Jun; 132(12)989-93.

Score: 0.614
Polycystic ovary syndrome and hyperandrogenism as a risk factor for cardiovascular disease.
H Martikainen ... M R Järvelin
Int J Circumpolar Health 1998 Jul; 57(2-3)133-7.

Score: 0.613
Countertransference phenomena and personality pathology in clinical practice: an empirical investigation.
Ephi Betan ... Drew Westen
Am J Psychiatry 2005 May; 162(5)890-8.

Score: 0.598
Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome?
T L Loucks ... D S Guzick
Fertil Steril 2000 Sep; 74(3)547-52.

Score: 0.590
Serum free testosterone in polycystic ovary syndrome measured with a new reference method.
T A Penttilä ... K Irjala
Fertil Steril 1996 Jan; 65(1)55-60.

Score: 0.589
Insulin-lowering agents in the management of polycystic ovary syndrome.
Vincenzo De Leo ... Felice Petraglia
Endocr Rev 2003 Oct; 24(5)633-67.

Score: 0.583
Polycystic ovary syndrome and cardiovascular disease: a premature association?
Richard S Legro
Endocr Rev 2003 Jun; 24(3)302-12.

Score: 0.581
Insulin resistance in polycystic ovarian disease.
Vishal Bhatia
South Med J 2005 Sep; 98(9)903-10; quiz 911-2, 923.

Score: 0.578
Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.
E O Talbott ... M Y Boudraux
Minerva Ginecol 2004 Feb; 56(1)27-39.

Score: 0.571
Pattern of care at the end of life: does age make a difference?
Christine Simmons ... Mark Clemons
J Clin Oncol 2005 Apr; 23(10)2441; author reply 2441-2.

Score: 0.570
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).
Hum Reprod 2004 Jan; 19(1)41-7.

Score: 0.568
Potential utility of insulin sensitizers in the treatment of patients with Polycystic ovary syndrome.
Fahri Bayram ... Fahrettin Kelestimur
Treat Endocrinol 2002 ; 1(1)45-53.

Score: 0.565
Polycystic ovarian syndrome: is community care appropriate?
S Gupta
Int J Clin Pract 1999 Jul-Aug; 53(5)359-62.

Score: 0.564
PCOS: a diagnostic challenge.
Ricardo Azziz
Reprod Biomed Online 2004 Jun; 8(6)644-8.

Score: 0.560
Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing.
P L Chang ... R A Lobo
J Clin Endocrinol Metab 2000 Mar; 85(3)995-1000.

Score: 0.555
Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study.
S Wild ... H Jacobs
Clin Endocrinol (Oxf) 2000 May; 52(5)595-600.

Score: 0.554
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.
Fertil Steril 2004 Jan; 81(1)19-25.

Score: 0.552
Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.
Teimuraz Apridonidze ... John E Nestler
J Clin Endocrinol Metab 2005 Apr; 90(4)1929-35.

Score: 0.551
The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks.
C G Solomon
Endocrinol Metab Clin North Am 1999 Jun; 28(2)247-63.

Score: 0.550
Polycystic ovary syndrome.
J A Kahn ... C M Gordon
Adolesc Med 1999 Jun; 10(2)321-36.

Score: 0.549
Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome.
K J Mather ... T J Anderson
J Clin Endocrinol Metab 2000 May; 85(5)1851-6.

Score: 0.545
Metformin treatment of PCOS during adolescence and the reproductive period.
Antonio La Marca ... Annibale Volpe
Eur J Obstet Gynecol Reprod Biol 2005 Jul; 121(1)3-7.

Score: 0.543
Obesity and the polycystic ovary syndrome.
A Gambineri ... R Pasquali
Int J Obes Relat Metab Disord 2002 Jul; 26(7)883-96.

Score: 0.543
Coronary heart disease risk factors in women with polycystic ovary syndrome.
E Talbott ... L Kuller
Arterioscler Thromb Vasc Biol 1995 Jul; 15(7)821-6.

Score: 0.543
Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications.
J E Nestler
Semin Reprod Endocrinol 1997 May; 15(2)111-22.

Score: 0.542
Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome.
S J Winters ... K P McHugh
Fertil Steril 2000 Apr; 73(4)724-9.

Score: 0.541
Sex hormone-binding globulin and female reproductive function.
N Botwood ... S Franks
J Steroid Biochem Mol Biol 1995 Jun; 53(1-6)529-31.

Score: 0.537
Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity.
K J Mather ... B Corenblum
Fertil Steril 2000 Jan; 73(1)150-6.

Score: 0.533
[Troglitazone for treatment of polycystic ovary syndrome]
M Sanaka ... Y Iwamoto
Nippon Rinsho 2000 Feb; 58(2)465-70.

Score: 0.533
Treatment of polycystic ovary syndrome with insulin-lowering agents.
Charles J Glueck ... Ping Wang
Expert Opin Pharmacother 2002 Aug; 3(8)1177-89.

Score: 0.532
Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women.
E O Talbott ... L H Kuller
Arterioscler Thromb Vasc Biol 2000 Nov; 20(11)2414-21.

Score: 0.532
The cardiovascular risk factor homocysteine is not elevated in young women with hyperandrogenism or hypoestrogenism.
Giuseppe Morgante ... Vincenzo De Leo
Gynecol Obstet Invest 2002 ; 53(4)200-3.

Score: 0.531
Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
G Dhindsa ... Vishal Bhatia
J Postgrad Med 2004 Apr-Jun; 50(2)140-4.

Score: 0.531
Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome.
Andromachi Vryonidou ... Amalia Dionyssiou-Asteriou
J Clin Endocrinol Metab 2005 May; 90(5)2740-6.

Score: 0.530
Impaired uterine perfusion associated with metabolic disorders in women with polycystic ovary syndrome.
Chebib Chekir ... Yuji Hiramatsu
Acta Obstet Gynecol Scand 2005 Feb; 84(2)189-95.

Score: 0.528
The predictive power of endocrine tests for the diagnosis of polycystic ovaries in women with oligoamenorrhea.
N O Turhan ... G Dilmen
Gynecol Obstet Invest 1999 ; 48(3)183-6.

Score: 0.525
Cardiovascular risk in PCOS.
David S Guzick
J Clin Endocrinol Metab 2004 Aug; 89(8)3694-5.

Score: 0.525
The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance.
V Jayagopal ... S L Atkin
J Clin Endocrinol Metab 2003 Apr; 88(4)1528-33.

Score: 0.523
Leptin concentrations in the polycystic ovary syndrome.
C S Mantzoros ... J S Flier
J Clin Endocrinol Metab 1997 Jun; 82(6)1687-91.

Score: 0.523
Sonographic parameters and hormonal status in lean and obese women with polycystic ovary syndrome.
C Sengos ... G Iatrakis
Clin Exp Obstet Gynecol 2000 ; 27(1)35-8.

Score: 0.522
[Non-radioimmunometric NT-ProBNP and BNP assays: impact of diluent, age, gender, BMI]
Y Alibay ... H Puy
Ann Biol Clin (Paris) 2005 Jan-Feb; 63(1)43-9.

Score: 0.520
Obesity, insulin, sex steroids and ovulation.
J E Nestler
Int J Obes Relat Metab Disord 2000 Jun; 24 Suppl 2()S71-3.

Score: 0.518
[Diagnosis and treatment of polycystic ovary syndrome]
R Gandar ... D Collin
J Gynecol Obstet Biol Reprod (Paris) 1999 Oct; 28(6)510-8.

Score: 0.518
Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.
Roger Hart ... Stephen Franks
Best Pract Res Clin Obstet Gynaecol 2004 Oct; 18(5)671-83.

Score: 0.516
[Diagnosis of polycystic ovary syndrome]
C Belosi ... A Lanzone
Minerva Ginecol 2004 Feb; 56(1)7-13.

Score: 0.516
[Polycystic ovary syndrome]
D Dewailly
J Gynecol Obstet Biol Reprod (Paris) 2000 May; 29(3)298-301.

Score: 0.516
Clinical and laboratory diagnostics of cardiovascular disease: focus on natriuretic peptides and cardiac ischemia.
Torbjørn Omland
Scand J Clin Lab Invest Suppl 2005 ; 240()18-24.

Score: 0.514
Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome.
Fleur R Cattrall ... David L Healy
Best Pract Res Clin Obstet Gynaecol 2004 Oct; 18(5)803-12.

Score: 0.514
[Metformin, an efficacious drug in the treatment of polycystic ovary syndrome]
S Hahn ... O E Janssen
Dtsch Med Wochenschr 2004 May; 129(19)1059-64.

Score: 0.513
Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.
G S Conway ... H S Jacobs
Clin Endocrinol (Oxf) 1992 Aug; 37(2)119-25.

Score: 0.511
Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction.
Kevin N Hogeveen ... Geoffrey L Hammond
J Clin Invest 2002 Apr; 109(7)973-81.

Score: 0.509
Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne.
P Timpatanapong ... A Rojanasakul
J Dermatol 1997 Apr; 24(4)223-9.

Score: 0.509
Genetics of polycystic ovarian syndrome.
Enza Fratantonio ... Aldo E Calogero
Reprod Biomed Online 2005 Jun; 10(6)713-20.

Score: 0.509
Insulin regulation of human ovarian androgens.
J E Nestler
Hum Reprod 1997 Oct; 12 Suppl 1()53-62.

Score: 0.508
The plasma homocysteine levels are increased in polycystic ovary syndrome.
Giuseppe Loverro ... Luigi Selvaggi
Gynecol Obstet Invest 2002 ; 53(3)157-62.

Score: 0.507
Which hormone tests for the diagnosis of polycystic ovary syndrome?
S Robinson ... R N Clayton
Br J Obstet Gynaecol 1992 Mar; 99(3)232-8.

Score: 0.507
Polycystic ovarian syndrome (PCOS) and insulin resistance.
K H Park ... H C Lee
Int J Gynaecol Obstet 2001 Sep; 74(3)261-7.

Score: 0.507
Diagnosis of polycystic ovary syndrome.
R J Chang ... S E Katz
Endocrinol Metab Clin North Am 1999 Jun; 28(2)397-408, vii.

Score: 0.506
Polycystic ovary (Stein-Leventhal) syndrome: etiology, complications, and treatment.
Karri Lynn Hoyt ... Margaret C Schmidt
Clin Lab Sci 2004 ; 17(3)155-63.

Score: 0.504
The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
K Unlühizarci ... A Tutuş
Clin Endocrinol (Oxf) 1999 Aug; 51(2)231-6.

Score: 0.504
Polycystic ovary syndrome after menopause: a case report.
Samuel Pauli ... Rogerio A Lobo
J Reprod Med 2004 Jun; 49(6)491-4.

Score: 0.503
Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia.
S Hahn ... O E Janssen
Horm Metab Res 2005 Jul; 37(7)438-44.

Score: 0.502
Obesity regulates bioavailable testosterone levels in women with or without polycystic ovary syndrome.
T L Penttilä ... K Irjala
Fertil Steril 1999 Mar; 71(3)457-61.

Score: 0.502
Metformin and polycystic ovary syndrome: a literature review.
Khalid A Awartani ... Anthony P Cheung
J Obstet Gynaecol Can 2002 May; 24(5)393-401.

Score: 0.502
Cardiovascular risk in women with polycystic ovarian syndrome.
D S Guzick
Semin Reprod Endocrinol 1996 Feb; 14(1)45-9.

Score: 0.501
Ovarian pregnancy in polycystic ovary syndrome: a case report.
N A Cataldo
Int J Fertil 1992 May-Jun; 37(3)144-5.

Score: 0.500
Serum total renin is elevated in women with polycystic ovarian syndrome.
T A Jaatinen ... K Irjala
Fertil Steril 1995 May; 63(5)1000-4.

Score: 0.499
Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.
Sandeep R Das ... James A de Lemos
Circulation 2005 Oct; 112(14)2163-8.

Score: 0.499
Health gains by using natriuretic peptides in diagnosis, prognosis and treatment.
Mark Richards ... Sue Wright
Scand J Clin Lab Invest Suppl 2005 ; 240()129-37.

Score: 0.497
Diagnosis and treatment of polycystic ovarian syndrome and insulin resistance.
Amy Fleischman ... Joan Mansfield
Pediatr Ann 2005 Sep; 34(9)733-8, 741-2.

Score: 0.497
Dyslipidemia with particular regard to apolipoprotein profile in association with polycystic ovary syndrome: a study among Indian women.
A Maitra ... P K Meherji
Int J Fertil Womens Med 2001 Sep-Oct; 46(5)271-7.

Score: 0.496
[The effects of hyperinsulinmia and insulin-like growth factor-1 on hyperandrogenism in polycystic ovarian syndrome]
X Liang ... Q Fan
Zhonghua Yi Xue Za Zhi 1997 Apr; 77(4)266-9.

Score: 0.495
Electrocautery in polycystic ovary syndrome.
K Tasaka ... O Tanizawa
Horm Res 1990 ; 33 Suppl 2()40-2.

Score: 0.494
Epithelial ovarian cancer risk among women with polycystic ovary syndrome.
J M Schildkraut ... C Hughes
Obstet Gynecol 1996 Oct; 88(4 Pt 1)554-9.

Score: 0.493
Polycystic ovary syndrome in adolescence.
Colleen Buggs ... Robert L Rosenfield
Endocrinol Metab Clin North Am 2005 Sep; 34(3)677-705, x.

Score: 0.493
Three-dimensional assessment of ultrasound features in women with clomiphene citrate-resistant polycystic ovarian syndrome (PCOS): ovarian stromal volume does not correlate with biochemical indices.
Luciano G Nardo ... Vik Khullar
Hum Reprod 2002 Apr; 17(4)1052-5.

Score: 0.492
Genetic basis of metabolic abnormalities in polycystic ovary syndrome: implications for therapy.
Belén Roldán ... Héctor F Escobar-Morreale
Am J Pharmacogenomics 2004 ; 4(2)93-107.

Score: 0.492
The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
J Holte ... L Wide
Clin Endocrinol (Oxf) 1994 Oct; 41(4)473-81.

Score: 0.492
How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
G A Kaltsas ... A B Grossman
Clin Endocrinol (Oxf) 2000 Oct; 53(4)493-500.

Score: 0.491
Type 2 diabetes and the polycystic ovary syndrome.
B Pelusi ... R Pasquali
Minerva Ginecol 2004 Feb; 56(1)41-51.

Score: 0.491
Presence of metabolic risk factors in non-obese PCOS sisters: evidence of heritability of insulin resistance.
E Diamanti-Kandarakis ... A Aessopos
J Endocrinol Invest 2004 Nov; 27(10)931-6.

Score: 0.491
Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?
Kai I Cheang ... John E Nestler
Reprod Biomed Online 2004 Apr; 8(4)440-7.

Score: 0.490
Polycystic ovary syndrome--a management update.
Michael F Costello
Aust Fam Physician 2005 Mar; 34(3)127-33.

Score: 0.489
Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome.
A Tolino ... C L De Falco
Eur J Obstet Gynecol Reprod Biol 2005 Mar; 119(1)87-93.

Score: 0.487
Endocrine characteristics of polycystic ovary syndrome (PCOS).
A Szilágyi ... I Szabó
Indian J Exp Biol 2003 Jul; 41(7)694-700.

Score: 0.487
Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
K H Chou ... P M Spritzer
Horm Metab Res 2003 Feb; 35(2)86-91.

Score: 0.487
Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipid-lipoprotein levels.
S Lemieux ... E M Greenblatt
J Clin Endocrinol Metab 1999 Nov; 84(11)4278-82.

Score: 0.485
Cardiovascular risk factors in young Czech females with polycystic ovary syndrome.
J Vrbíková ... L Stárka
Hum Reprod 2003 May; 18(5)980-4.

Score: 0.485
Clinical, biochemical and ultrasonographic characteristics of Scandinavian women with PCOS.
Eszter Vanky ... Sven Magnus Carlsen
Acta Obstet Gynecol Scand 2004 May; 83(5)482-6.

Score: 0.485
Obesity and polycystic ovary syndrome.
S Franks ... D Hamilton-Fairley
Ann N Y Acad Sci 1991 ; 626()201-6.

Score: 0.485
Smaller LDL particle size in women with polycystic ovary syndrome compared to controls.
S Dejager ... G Turpin
Clin Endocrinol (Oxf) 2001 Apr; 54(4)455-62.

Score: 0.484
Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
Miriam E Silfen ... Sharon E Oberfield
J Clin Endocrinol Metab 2003 Oct; 88(10)4682-8.

Score: 0.483
Abstract:
The Dallas Heart Study (DHS) is a probability-based cross-sectional study over-sampled for African-Americans designed to improve the understanding of preclinical determinants of cardiovascular disease. Through state-of-the art characterization of phenotypes and genotypes, this study is designed to generate and test hypotheses for improved diagnosis and treatment of cardiovascular disease.

1) Gender Differences in Circulating B-type Natriuretic Peptides
Further details are in the applicant’s research proposal along with preliminary data. We tested the hypothesis that BNP and NT-proBNP levels are regulated by sex hormones. Univariable linear regression and multivariable analyses were performed to evaluate the association of BNP and NT-proBNP with sex steroid hormone levels in women, ages 35 to 49. Log transformed SHBG, an indirect measure of the free estrogen to free testosterone ratio, was strongly associated with log BNP and log NT-proBNP.
2) Reynolds Women’s Study
Polycystic ovarian syndrome (PCOS) is a heterogeneous condition with the clinical features or biochemical findings of hyperandrogenism, anovulatory cycles and polycystic ovarian morphology (PCOM). An estimated 20% of reproductive age women have PCOM, and an estimated 10% of the population has PCOS. PCOS is also associated with metabolic factors recognized to increase cardiovascular risk – lipid abnormalities, insulin resistance and obesity. There is conflicting data about the translation of these risk factors to coronary artery disease and the relative contributions of the intermediate phenotypes of hyperandrogenism and PCOM. The Reynolds Women’s Study was designed to examine the associations of subclinical PCOS with subclinical coronary artery disease and coronary artery disease risk factors among reproductive age women. It is a subset of the DHS, women ages 35 to 49, with additional survey information about menstrual cycles, serologic measurements of total testosterone, SHBG, FSH and LH, and MRI data about ovarian structure.
??

??

??

??

Current Research Experience in Women’s Cardiovascular Health
Alice Y. Chang, M.D

Keywords extracted from the abstract: [ eliminated words list ]
Count Word
6.000 1
6.000 2
1.457 abnormalities
1.615 additional
3.560 african-americans
1.514 age
4.332 ages
3.486 alice
1.710 analyses
3.582 anovulatory
6.000 applicant’s
2.500 art
3.595 artery
2.094 associated
1.438 association
2.237 associations
3.430 b-type
1.777 biochemical
8.374 bnp
5.060 cardiovascular
2.337 chang
1.744 characterization
2.013 circulating
0.816 clinical
1.780 condition
2.845 conflicting
2.483 contributions
3.497 coronary
2.036 cross-sectional
1.462 current
Count Word
4.353 cycles
2.633 dallas
2.310 data
5.058 designed
2.565 details
2.199 determinants
7.801 dhs
0.770 diagnosis
1.256 differences
2.916 disease
3.645 estimated
1.823 estrogen
1.613 evaluate
1.654 experience
2.216 factors
1.573 features
1.238 findings
2.942 free
2.288 fsh
1.313 further
2.061 gender
2.297 generate
2.408 genotypes
0.783 health
1.036 heart
2.329 heterogeneous
1.350 hormone
1.555 hormones
7.409 hyperandrogenism
2.511 hypotheses
Count Word
1.717 hypothesis
1.811 improve
1.613 improved
1.070 increase
2.056 indirect
1.363 information
1.292 insulin
1.897 intermediate
1.893 levels
1.942 lh
1.804 linear
1.553 lipid
6.844 log
1.800 measure
1.558 measurements
2.384 menstrual
1.655 metabolic
1.977 morphology
1.986 mri
3.353 multivariable
2.230 natriuretic
11.302 nt-probnp
1.935 obesity
4.769 ovarian
5.747 over-sampled
14.278 pcom
10.202 pcos
1.512 peptides
1.222 performed
4.732 phenotypes
Count Word
5.367 polycystic
1.201 population
2.442 preclinical
1.989 preliminary
4.827 probability-based
2.830 proposal
1.428 ratio
1.964 recognized
1.683 regression
1.961 regulated
1.501 relative
4.004 reproductive
1.313 resistance
5.974 reynolds
2.815 risk
2.587 serologic
2.834 sex
6.469 shbg
5.044 state-of-the
1.962 steroid
1.803 strongly
1.291 structure
5.633 subclinical
2.294 subset
1.140 syndrome
1.470 tested
3.728 testosterone
1.152 total
2.194 transformed
2.074 translation
Count Word
0.777 treatment
1.789 understanding
4.462 univariable
3.682 women
16.352 women’s
RIC Statistics:
Extraction Method: Keyword Count with Lexical Variants Added
Eliminated words list: MedlinePlus List
Similarity Method: Weighted keyword count
Weighting Method: Term Frequency * Inverse Document Frequency
Database: Medline abstracts (1967 - Present)
Publication Type: All
Score Calculation Method: Cosine Similarity Method
Sort by: Score
Submission date and time: 11-8-2005, 15:24:44
Computation time: 00:00:05
Last updated: Tuesday, 08-Nov-2005 15:24:49 CST